Brookfield Corp’s Outset Medical OM Stock Holding History

Brookfield Corp’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,049	Closed	-$3.5M	–	751
2022 Q4	$3.5M	Buy	+9,049	New	+$2.55M	0.01%	323

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Brookfield Corp's OM Position: Q1 2023 in Review

Brookfield Corp sold out of Outset Medical (OM) in Q1 2023, closing a stake of 9,049 shares — an estimated $3.5M sold.

Brookfield Corp first reported a position in OM in Q4 2022 and held it in 1 quarter. The position peaked at $3.5M in Q4 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

Brookfield Corp reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 9,049 Outset Medical shares in Q1 2023, an estimated $3.5M.
Brookfield Corp first reported a position in Outset Medical in Q4 2022 and held it in 1 quarter.
Brookfield Corp's Outset Medical position peaked at $3.5M in Q4 2022.
162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.